ReNeuron : First subject treated at Oxford Eye Hospital
First subject treated at Oxford Eye Hospital in Phase 2a RP trial Oxford University Hospitals NHS Foundation Trust activatedas ReNeuron's first UK... | October 18, 2021
Stay updated with breaking news from Reneuron Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First subject treated at Oxford Eye Hospital in Phase 2a RP trial Oxford University Hospitals NHS Foundation Trust activatedas ReNeuron's first UK... | October 18, 2021
TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru | Financial News
A glance at some of the day's highlights from the Proactive Investors newswire
Tintra, which has undergone various reinventions since floating on the junior market as The Weather Lottery in 2006, saw its shares surge 54 per cent to 103.4p.
The company's technology could help unlock treatments for stroke, Parkinson’s and Huntington’s diseases